id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
EPA-HQ-OAR-2006-0159-0060,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007,Rule,Federal Register Document,2007-06-12T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,E7-11319,0,0,090000648024eb61
EPA-HQ-OAR-2006-0159-0061,EPA,EPA-HQ-OAR-2006-0159,2007 Final Rule Submitted to OMB (Office of Management and Budget),Supporting & Related Material,Federal Register Document,2007-06-12T04:00:00Z,2007,6,,,2011-06-11T16:02:05Z,,0,0,090000648024e9f4
EPA-HQ-OAR-2006-0159-0051,EPA,EPA-HQ-OAR-2006-0159,Second Letter to USEPA from the US Stakeholder Group on MDI Transition,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:46Z,,0,0,090000648023dfc1
EPA-HQ-OAR-2006-0159-0059,EPA,EPA-HQ-OAR-2006-0159,FDA (Food and Drug Administration) Rulemaking: Use of Ozone-Depleting Substances; Removal of Essential-Use Designations (70 FR 17168),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:04Z,,0,0,0900006480249f74
EPA-HQ-OAR-2006-0159-0056,EPA,EPA-HQ-OAR-2006-0159,Decision XII/2 from the 12th Meeting of the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:56Z,,0,0,0900006480249f5f
EPA-HQ-OAR-2006-0159-0050,EPA,EPA-HQ-OAR-2006-0159,Letter to USEPA from the US Stakeholders Group on MDI Transition,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:44Z,,0,0,090000648023dfb7
EPA-HQ-OAR-2006-0159-0053,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential-Use Allowances for Calendar Year 2002; and Extension of the De Minimis Exemption for Essential Laboratory and Analytical Uses Through Calendar Year 2005; Final Rule (67 FR 6352),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f4b
EPA-HQ-OAR-2006-0159-0055,EPA,EPA-HQ-OAR-2006-0159,Decision XVIII/7 from the 18th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:54Z,,0,0,0900006480249f5a
EPA-HQ-OAR-2006-0159-0058,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone; Extension of Global Laboratory and Analytical Use Exemption for Essential Class I Ozone Depleting Substances (70 FR 77048),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f71
EPA-HQ-OAR-2006-0159-0057,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2005; Final Rule (70 FR 49836),Supporting & Related Material,Federal Register Document,2007-06-08T04:00:00Z,2007,6,,,2011-06-11T16:02:03Z,,0,0,0900006480249f68
EPA-HQ-OAR-2006-0159-0049,EPA,EPA-HQ-OAR-2006-0159,Schering-Plough Letter to U.S. Government Stakeholders,Supporting & Related Material,"Letter, Memorandum, Email",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:43Z,,0,0,090000648023dfa9
EPA-HQ-OAR-2006-0159-0052,EPA,EPA-HQ-OAR-2006-0159,Decision VIII/10 from the 8th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:47Z,,0,0,0900006480249f47
EPA-HQ-OAR-2006-0159-0054,EPA,EPA-HQ-OAR-2006-0159,Decision XVII/5 from the 17th Meeting of the Parties to the Montreal Protocol,Supporting & Related Material,"Adjudication, Brief, Decision, Decree, Motion, Order",2007-06-08T04:00:00Z,2007,6,,,2007-06-08T15:18:52Z,,0,0,0900006480249f56
EPA-HQ-OAR-2006-0159-0044,EPA,EPA-HQ-OAR-2006-0159,"2007 Food and Drug Administration (FDA) Determination Letter (Revised, May 4, 2007)",Supporting & Related Material,"Letter, Memorandum, Email",2007-05-31T04:00:00Z,2007,5,,,2007-05-31T14:43:58Z,,0,0,090000648024599b
EPA-HQ-OAR-2006-0159-0043,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for CONFIDENTIAL supplementary information received by EPA from Robert M. Sussman of Latham and Watkins, LLC, council for Amphastar Pharmaceuticals Inc., and Armstrong Pharmaceuticals, Inc. on February 22, 2007",Supporting & Related Material,Other,2007-02-27T05:00:00Z,2007,2,,,2007-02-27T18:26:42Z,,0,0,090000648020bd6b
EPA-HQ-OAR-2006-0159-0033,EPA,EPA-HQ-OAR-2006-0159,"Notes from meeting between representatives from Amphastar Pharmaceuticals, Inc./Armstrong Pharmaceuticals Inc. and USEPA on November 30, 2006",Supporting & Related Material,Meeting/Teleconference Materials,2006-12-06T05:00:00Z,2006,12,,,2012-03-24T19:34:44Z,,0,0,09000064801e76bb
EPA-HQ-OAR-2006-0159-0001,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2007,Proposed Rule,Federal Register Document,2006-11-03T12:49:10Z,2006,11,2006-11-03T12:49:10Z,2006-12-05T04:59:59Z,2011-06-11T16:02:04Z,E6-18581,0,0,09000064801dd141
EPA-HQ-OAR-2006-0159-0021,EPA,EPA-HQ-OAR-2006-0159,Placeholder for the Regulatory Impact Analysis RIA,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:45Z,,0,0,09000064801dbe94
EPA-HQ-OAR-2006-0159-0008,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Schering Plough's response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:37Z,,0,0,09000064801db554
EPA-HQ-OAR-2006-0159-0018,EPA,EPA-HQ-OAR-2006-0159,SAMPLE 114 Letter for Allocation of Essential Use Allowances for Calendar Year 2007,Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:43Z,,0,0,09000064801dbe5e
EPA-HQ-OAR-2006-0159-0017,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Armstrong Pharmaceuticals, Inc.’s response to 114 letter regarding CFC stocks owned",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:42Z,,0,0,09000064801dbe40
EPA-HQ-OAR-2006-0159-0007,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Wyeth's response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:37Z,,0,0,09000064801db534
EPA-HQ-OAR-2006-0159-0016,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc.’s response to 114 letter regarding CFC stocks owned",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:42Z,,0,0,09000064801dbe3a
EPA-HQ-OAR-2006-0159-0013,EPA,EPA-HQ-OAR-2006-0159,Schering-Plough's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:40Z,,0,0,09000064801dbd2b
EPA-HQ-OAR-2006-0159-0015,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Wyeth's response to section 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:41Z,,0,0,09000064801dbe1d
EPA-HQ-OAR-2006-0159-0023,EPA,EPA-HQ-OAR-2006-0159,Decision IV/25- Essential uses,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:46Z,,0,0,09000064801dbef4
EPA-HQ-OAR-2006-0159-0004,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Boehringer Ingelheim Pharmaceuticals, Inc’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:35Z,,0,0,09000064801d7f4b
EPA-HQ-OAR-2006-0159-0006,EPA,EPA-HQ-OAR-2006-0159,Placeholder for 3M’s response to Section 114 letter,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:36Z,,0,0,09000064801d7fbd
EPA-HQ-OAR-2006-0159-0022,EPA,EPA-HQ-OAR-2006-0159,Protection of Stratospheric Ozone: Allocation of Essential Use Allowances for Calendar Year 2006,Supporting & Related Material,Federal Register Document,2006-11-03T05:00:00Z,2006,11,,,2011-06-11T16:02:04Z,,0,0,09000064801dbedc
EPA-HQ-OAR-2006-0159-0024,EPA,EPA-HQ-OAR-2006-0159,Decision XVI/12-Essential-use nominations for Parties not operating under paragraph 1 of Article 5 of the Montreal Protocol for controlled substances for 2005 and 2006,Supporting & Related Material,,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:47Z,,0,0,09000064801dbf01
EPA-HQ-OAR-2006-0159-0020,EPA,EPA-HQ-OAR-2006-0159,Decision XVII/5: Essential-use nominations for Parties not operating under paragraph 1 of Article 5 for controlled substances for 2006 and 2007,Supporting & Related Material,"Guidance, Interpretation, Policy, Procedure",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:44Z,,0,0,09000064801dbe7e
EPA-HQ-OAR-2006-0159-0010,EPA,EPA-HQ-OAR-2006-0159,SAMPLE 114 LETTER for CFC Stocks Owned,Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:38Z,,0,0,09000064801dbcf0
EPA-HQ-OAR-2006-0159-0019,EPA,EPA-HQ-OAR-2006-0159,"Letter to Brian McLean, Director, Office of Atmospheric Programs, USEPA re: responding to the March 23 letter requesting the Food and Drug Administration's (FDA) re: 2007 Essential Use Allowances",Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:44Z,,0,0,09000064801dbe6a
EPA-HQ-OAR-2006-0159-0003,EPA,EPA-HQ-OAR-2006-0159,"Letter to Mr. Andrew C. von Eschenbach, M.D., Acting Commissioner of Food and Drugs, Food and Drug Administration",Supporting & Related Material,"Letter, Memorandum, Email",2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:34Z,,0,0,09000064801d7e7f
EPA-HQ-OAR-2006-0159-0005,EPA,EPA-HQ-OAR-2006-0159,"Placeholder for Inyx USA, Ltd.’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:36Z,,0,0,09000064801d7f7a
EPA-HQ-OAR-2006-0159-0011,EPA,EPA-HQ-OAR-2006-0159,Placeholder for Inyx USA Ltd.'s response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:39Z,,0,0,09000064801dbd07
EPA-HQ-OAR-2006-0159-0002,EPA,EPA-HQ-OAR-2006-0159,"CBI Placeholder for Armstrong Pharmaceuticals, Inc.’s response to Section 114 letter",Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:34Z,,0,0,09000064801d76c1
EPA-HQ-OAR-2006-0159-0014,EPA,EPA-HQ-OAR-2006-0159,Honeywell's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:41Z,,0,0,09000064801dbd47
EPA-HQ-OAR-2006-0159-0012,EPA,EPA-HQ-OAR-2006-0159,3M's response to 114 letter regarding CFC stocks owned,Supporting & Related Material,Other,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:40Z,,0,0,09000064801dbd1e
EPA-HQ-OAR-2006-0159-0009,EPA,EPA-HQ-OAR-2006-0159,United States' Nomination of The Aerosol Metered Dose Inhaler (MDI) As An Essential Use,Supporting & Related Material,,2006-11-03T05:00:00Z,2006,11,,,2006-11-03T13:00:38Z,,0,0,09000064801dbc8d